9158 Stock Overview
CUC Inc. offers healthcare services in Japan, Asia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
CUC Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,733.00 |
| 52 Week High | JP¥5,130.00 |
| 52 Week Low | JP¥1,712.00 |
| Beta | 0 |
| 1 Month Change | -34.60% |
| 3 Month Change | -32.33% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -62.33% |
Recent News & Updates
Shareholder Returns
| 9158 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | -24.2% | -0.6% | -0.5% |
| 1Y | n/a | 2.9% | 28.3% |
Return vs Industry: Insufficient data to determine how 9158 performed against the JP Healthcare industry.
Return vs Market: Insufficient data to determine how 9158 performed against the JP Market.
Price Volatility
| 9158 volatility | |
|---|---|
| 9158 Average Weekly Movement | 8.2% |
| Healthcare Industry Average Movement | 3.7% |
| Market Average Movement | 4.1% |
| 10% most volatile stocks in JP Market | 8.1% |
| 10% least volatile stocks in JP Market | 2.3% |
Stable Share Price: 9158's share price has been volatile over the past 3 months.
Volatility Over Time: 9158's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3,159 | Keita Hamaguchi | www.cuc-jpn.com |
CUC Inc. offers healthcare services in Japan, Asia and internationally. It provides hospital care, dialysis care, visiting nurses, and home hospices services, as well as management support services for healthcare institutions; and healthcare consulting services. The company was founded in 2014 and is based in Minato-Ku, Japan.
CUC Inc. Fundamentals Summary
| 9158 fundamental statistics | |
|---|---|
| Market cap | JP¥50.80b |
| Earnings (TTM) | JP¥2.60b |
| Revenue (TTM) | JP¥33.03b |
19.6x
P/E Ratio1.5x
P/S RatioIs 9158 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 9158 income statement (TTM) | |
|---|---|
| Revenue | JP¥33.03b |
| Cost of Revenue | JP¥17.10b |
| Gross Profit | JP¥15.92b |
| Other Expenses | JP¥13.33b |
| Earnings | JP¥2.60b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 88.52 |
| Gross Margin | 48.22% |
| Net Profit Margin | 7.86% |
| Debt/Equity Ratio | 65.8% |
How did 9158 perform over the long term?
See historical performance and comparison